Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
22nd Nov 2022 7:00 am RNS Blenrep US Update
21st Nov 2022 3:30 pm RNS Director/PDMR Shareholding
18th Nov 2022 4:00 pm RNS Publication of EMTN Supplementary Prospectus
15th Nov 2022 4:00 pm RNS Block listing Interim Review
15th Nov 2022 3:53 pm RNS Final results of outstanding Notes Tender Offer
15th Nov 2022 7:00 am RNS Interim results of outstanding Notes Tender Offer
11th Nov 2022 7:00 am RNS GSK Update: Zejula 2L in US
10th Nov 2022 6:10 pm RNS Sanofi-GSK COVID booster vaccine approved by EU
10th Nov 2022 3:30 pm RNS Director/PDMR Shareholding
10th Nov 2022 9:00 am RNS Block Listing Application
8th Nov 2022 9:26 am RNS Launch of Tender Offer for outstanding Notes
7th Nov 2022 7:00 am RNS DREAMM-3 phase III trial for Blenrep
3rd Nov 2022 1:00 pm RNS Publication of Suppl.Prospcts
3rd Nov 2022 7:00 am RNS IDMC recommends gepotidacin early efficacy stop
2nd Nov 2022 7:01 am RNS 3rd Quarter Results
2nd Nov 2022 7:00 am RNS GSK RSV vaccine: US FDA Priority Review
1st Nov 2022 3:00 pm RNS Total Voting Rights
28th Oct 2022 7:00 am RNS EMA validates MAA for cabotegravir LA for PrEP
28th Oct 2022 7:00 am RNS EMA accepts GSK RSV older adult vaccine for review
27th Oct 2022 7:05 am RNS GSK announces FDA meeting outcome on daprodustat
27th Oct 2022 7:00 am RNS ContRAst phase III programme for otilimab update
25th Oct 2022 10:00 am RNS Board Committee Changes
21st Oct 2022 7:00 am RNS RSV older adult vaccine submission in Japan
17th Oct 2022 7:00 am RNS Menveo new single-vial approve by US FDA
17th Oct 2022 7:00 am RNS Menveo new single-vial approved by US FDA
14th Oct 2022 2:11 pm RNS Director/PDMR Shareholding
13th Oct 2022 12:46 pm RNS Director/PDMR Shareholding
13th Oct 2022 9:44 am RNS Director/PDMR Shareholding
13th Oct 2022 8:26 am RNS Director/PDMR Shareholding
13th Oct 2022 7:00 am RNS Efficacy results for GSK’s older adult RSV vaccine
12th Oct 2022 11:42 am RNS Director/PDMR Shareholding
10th Oct 2022 7:00 am RNS US FDA approves Boostrix maternal immunisation
7th Oct 2022 4:38 pm RNS Director/PDMR Shareholding
7th Oct 2022 4:24 pm RNS Director/PDMR Shareholding
3rd Oct 2022 10:10 am RNS Total Voting Rights
30th Sep 2022 5:21 pm RNS Director/PDMR Shareholding
26th Sep 2022 5:09 pm RNS Director/PDMR Shareholding
26th Sep 2022 7:00 am RNS GSK Chief Financial Officer succession
22nd Sep 2022 2:00 pm RNS US FDA ODAC review of Zejula Phase III NOVA trial
22nd Sep 2022 7:00 am RNS GSK and Spero Therapeutics licence for tebipenem
FTSE 100 Latest
Value8,975.66
Change108.64